Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease

Journal of Nutritional Biochemistry

Volumn 19, Issue 2, 2008, Pages 101-108

  Hansen, Rodney A ^a   Harris, Mary A ^b   Pluhar, G Elizabeth ^c   Motta, Tatiana ^d   Brevard, Sean ^b   Ogilvie, Gregory K ^e   Fettman, Martin J ^b   Allen, Kenneth G D ^b  

^a WEBER STATE UNIVERSITY   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e Angel Care Cancer Center   (United States)

Author keywords

Docosahexaenoic acid (DHA); Dogs; Eicosapentaenoic acid (EPA); Fish oil; Inflammatory joint disease; Matrix metalloproteinases

Indexed keywords

ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; FISH OIL; GELATINASE A; GELATINASE B; ICOSAPENTAENOIC ACID; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HINDLIMB; KNEE; KNEE ARTHRITIS; KNEE CRUCIATE LIGAMENT; KNEE INSTABILITY; KNEE LIGAMENT INJURY; MALE; NONHUMAN; PROTEIN EXPRESSION; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS; DIET; DOGS; FEMALE; FISH OILS; KNEE JOINT; MALE; MATRIX METALLOPROTEINASES; SYNOVIAL MEMBRANE;

CANIS FAMILIARIS;

EID: 37649020297     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.01.008     Document Type: Article

References (42)

1. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacology 70 (1996) 163-182
2. Stamenkovic I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J Pathol 200 (2003) 448-464
3. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem 267 (1992) 515-519
4. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., and Steele R.J.C. Matrix metalloproteinases. Br J Surg 84 (1997) 160-166
5. Mengshol J.A., Kimberlee S.M., and Brinckerhoff C.E. Matrix metalloproteinases as therapeutic targets in arthritic disease. Arthritis Rheum 46 (2002) 13-20
6. Leyland H., Gentry J., Arthur M.J., and Benyon R.C. The plasminogen-activating system in hepatic stellate cells. Hepatology 24 (1996) 1172-1178
7. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological function. Eur J Cell Biol 74 (1997) 111-122
8. Imai K., Ohta S., Matsumoto T., Fujimoto N., Sato H., Seiki M., et al. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 151 (1997) 245-256
9. Elliott S., and Cawston T. The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders. Drug Aging 18 (2001) 87-99
10. Muir P., Danova N.A., Argyle D.J., Manley P.A., and Hao Z. Collagenolytic protease expression in cranial cruciate ligament and stifle synovial fluid in dogs with cranial cruciate ligament rupture. Vet Surgery 34 (2005) 482-490
11. Fujita Y., Hara Y., Nezu Y., Schulz K.S., and Tagawa M. Proinflammatory cytokine activities, matrix metalloproteinase activity, and sulfated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture. Vet Surgery 35 (2006) 369-376
12. Comerford E.J., Innes J.F., Tarlton J.F., and Bailey A.J. Investigation of the composition, turnover, and thermal properties of ruptured cranial cruciate ligaments of dogs. Am J Vet Res 65 (2004) 1136-1141
13. Volk S.W., Kapatkin A.S., Haskins M.E., Walton R.M., and D'Angelo M. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. Am J Vet Res 64 (2003) 1225-1233
14. Barrett J.G., Hao Z., Graf B.K., Kaplan L.D., Heiner J.P., and Muir P. Inflammatory changes in ruptured canine cranial and human anterior cruciate ligaments. Am J Vet Res 66 (2005) 2073-2080
15. Curtis C.L., Rees S.G., Little C.B., Flannery C.R., Hughes C.E., Wilson C., et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum 46 (2002) 1544-1553
16. Kim H.H., Shin C.M., Park C.H., Kim K.H., Cho K.H., Eun H.C., et al. Eicosapentaenoic acid inhibits UV-induced MMP-1 expression in human dermal fibroblasts. J Lipid Res 46 (2005) 1712-1720
17. Rayward R.M., Thomson D.G., Davies J.V., Innes J.F., and Whitelock R.G. Progression of osteoarthritis following TPLO surgery: a prospective radiographic study of 40 dogs. J Small Anim Pract 45 (2004) 92-97
18. Slocum B., and Slocum T.D. Tibial plateau leveling osteotomy for repair of cranial ligament rupture in the canine. Vet Clin North Am Small Anim Pract 23 (2000) 777-795
19. Moore K.W., and Read R.A. Rupture of the cranial cruciate ligament in dogs - part I. Compendium 18 (1996) 223-233
20. Moore K.W., and Read R.A. Rupture of the cranial cruciate ligament in dogs - part II diagnosis and management. Compendium 18 (1996) 381-390
21. Ohta A., Mayo M.C., Kramer N., and Lands W.E. Rapid analysis of fatty acids in plasma lipids. Lipids 25 (1990) 742-747
22. Huessen C., and Dowdle E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecylsulfate and copolymerized substrates. Anal Biochem 102 (1980) 196-202
23. Roeb E., Dietrich C.G., Winograd R., Arndt M., Breuer B., Fass J., et al. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 92 (2001) 2680-2691
24. Perez M.A., Hansen R.A., Harris M.A., and Allen K.G.D. Dietary docosahexaenoic acid alters pregnant rat reproductive tissue prostaglandin and matrix metalloproteinase production. J Nutr Biochem 17 (2006) 446-453
25. Coughlan A.R., Robertson D.H.L., Burke R., Beynon R.J., and Carter S.D. Isolation and identification of canine matrix metalloproteinase-2 (MMP-2). J Vet 155 (1998) 231-237
26. Fujimoto N., Tokai H., Iwata K., Okada Y., and Hayakawa T. Determination of tissue inhibitor of metalloproteinases-2 (TIMP-2) in experimental animals using monoclonal antibodies against TIMP-2-specific oligopeptides. J Immunol Methods 187 (1995) 33-39
27. Johnson A.J., Kline D.L., and Alkjaersig N. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968. Thromb Diath Haemorrh 21 (1969) 259-272
28. Hansen R.A., Ogilvie G.K., Davenport D.J., Gross K.L., Walton J.A., Richardson K.L., et al. Duration of effects of dietary fish oil supplementation on serum eicosapentaenoic acid and docosahexaenoic acid concentrations in dogs. Am J Vet Res 59 (1998) 864-868
29. Ogilvie G.K., Fettman M.J., Mallinckrodt C.H., Walton J.A., Hansen R.A., Davenport D.J., et al. Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo controlled study. Cancer 88 (2000) 1916-1928
30. Mengshol J.A., Mix K.S., and Brinckerhoff C.E. Matrix metalloproteinases as therapeutic targets in arthritic disease: bulls-eye or missing the target. Arthritis Rheum 46 (2002) 13-20
31. Faisal Khan K.M., Howe L.R., and Falcone D.J. Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J Biol Chem 279 (2004) 22039-22046
32. Calder P.C. N-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41 (1997) 203-234
33. Espersen G.T., Grunnet N., Lervang N.H., Nielson G.L., Thomsen B.S., Faarvang K.L., et al. Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 11 (1992) 393-395
34. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., and James M.J. The effect of human necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63 (1996) 116-122
35. Tsuchiya K., Maloney W.J., Vu T., et al. OA: Differential expression of matrix metalloproteinase-9 mRNA in nonfibrillated and fibrillated cartilage. J Orthop Res 15 (1997) 94-100
36. Constantinescu C.S., Grygar C., Kappos L., and Leppert D. Interleukin 15 stimulates production of matrix matelloproteinase-9 and tissue inhibitor of metalloprotein-1 by human peripheral blood mononuclear cells. Cytokine 13 (2001) 244-247
37. Cleaver C.S., Rowan A.D., and Cawston T.E. Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines. Ann Rheum Dis 60 (2001) 150-157
38. Hermann J.A., Hall M.A., Maini R.N., Feldmann M., and Brennan F.M. Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis. Arthritis Rheum 41 8 (1998) 1388-1397
39. McCabe A.J., Wallace J.M., Gilmore W.S., et al. Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1. J Nutr Biochem 16 (2005) 17-22
40. Curtis C.L., Rees S.G., Cramp J., Flannery C.R., et al. Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc 61 (2002) 381-389
41. Curtis C.L., Hughes C.E., Flannery C.R., et al. N-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275 (2000) 721-724
42. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., and Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164 (2000) 2666